Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

Platelet-Rich Plasma (PRP) shows promise for hair growth and skin improvement in aesthetic surgery.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Many skin patients also have mental health issues, and doctors should treat both together.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Diabetes often causes various skin problems and complications.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.